Thirty-one polymorphisms of the PXR, SLCO1A2, SLCO1B1 and SLCO1B3 transporters were analysed using MALDI-TOF MS and revealed that none of the 31 polymorphisms showed an association with breast cancer risk or tumour characteristics [106]. Here, SLCO1B3 is linked to breast cancer.